Dr. Reddy's Laboratories Limited (DRREDDY) — Announcement | 23 July 2026
Dr. Reddy's Laboratories announced the availability of audio recordings from its July 22, 2026 earnings call for the quarter ended June 30, 2026, accessible via a provided web link for investor reference and record-keeping purposes.
About Dr. Reddy's Laboratories Limited (DRREDDY)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when DRREDDY files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track DRREDDY — Free💡 Ask AI about this filing
📊 More DRREDDY filings
- Announcement — 1 August 2026 Dr. Reddy's Laboratories announced that the U.S. FDA approved its rituximab biosimilar for the U.S. ...
- Announcement — 29 July 2026 Dr. Reddy's Laboratories announced that the US FDA completed a Pre-Approval Inspection and GMP check...
- Announcement — 29 July 2026 Dr. Reddy's Laboratories clarified on July 29, 2026 that a Business Standard news article about Thai...
- Announcement — 28 July 2026 Dr. Reddy's Laboratories reported a 5.6% YoY revenue decline to ₹8,071 crores in Q1 FY27, driven by ...
- Announcement — 28 July 2026 No summary available
🔥 Also filed on 23 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DRREDDY files new disclosures
Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DRREDDY — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research